Our data demonstrated that short-term irisin treatment was effective in increasing the cerebral expression of neutrophins in the hippocampus and/or the PFC in young healthy mice previously submitted to a behavioral paradigm of depression. This evidence concerns the gene FNDC5 and major depressive disorder.